BioSpace News Archive

WALTHAM, Mass., July 31, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies (RCTs) that may offer rapid-onset pain relief and restored function, today announced the appointment of E. Lynne Kelley, M.D., FACS as its Chief Medical Officer. Dr. Kelley brings more than 20 years of executive management and surgical experience in medical affairs, clinical operations, regulatory affairs and product development to His

Quartzy announced its plan to help labs across the United States save even more on supply shipments with free standard shipping for all orders over $99.

ZIKV-IG granted Fast Track designation by the U.S. Food and Drug Administration

Myriad Genetics, Inc. announced that it will hold its fiscal fourth-quarter 2018 sales and earnings conference call with investors and analysts at 4:30 p.m. EDT on Tuesday, August 14, 2018.

Progressive Care Inc. announced that its subsidiary, PharmCo, LLC, has received certification approval from LegitScript to provide verification that it is operating in compliance with applicable laws and regulation set forth to be a safe and credible online health resource.

RedHill Biopharma Ltd. today elaborated on the previously announced positive top-line results from the first Phase III study with orally-administered RHB-104 for Crohn’s disease (the MAP US study).

New guidelines from the American Heart Association mean that nearly one out of every two American adults with high blood pressure may be facing a choice about prescription drug treatment.

Savaria Corporation will release its 2018 second quarter results after market hours on August 8, 2018.

For more than 40 years, Medicaid beneficiaries, many of whom are among our nation’s most fragile citizens, have relied on non-emergency medical transportation (NEMT) for travel to and from medical appointments.

G100 advancing to late-stage development following FDA feedback